1560 Ratified PICO - Department of Health

The presence of 17p deletion without any signs of active disease is not an indication for treatment. ... Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia. ... The ESC considered that in current clinical practice del17p CLL/SLL patients were progressing quickly through a limited number of first-line treatment ... ................
................